Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MannKind Corp (NASDAQ:MNKD)

1.95
Delayed Data
As of Sep 25
 -0.03 / -1.52%
Today’s Change
0.67
Today|||52-Week Range
4.34
-38.75%
Year-to-Date

Today’s Trading

Previous close1.98
Today’s open2.01
Day’s range1.91 - 2.01
Volume1,808,886
Average volume (3 months)2,790,982
Market cap$207.3M
Dividend yield--
Data as of 4:00pm ET, 09/25/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-169.12%
Earnings growth (next 5 years)+26.80%
Revenue growth (last year)--
P/E ratio1.3
Price/Sales1.68
Price/Book--

Competitors

 Today’s
change
Today’s
% change
OCXOncoCyte Corp-0.05-0.76%
BDSIBioDelivery Sciences...0.000.00%
OMEDOncoMed Pharmaceutic...+0.11+2.46%
CLSDClearside Biomedical...0.000.00%
Data as of 7:59pm ET, 09/25/2017

Financials

Next reporting dateNovember 8, 2017
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$174.8M
Annual profit (last year)$125.7M
Net profit margin71.91%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michael E. Castagna
Chief Financial Officer &
Chief Accounting Officer
Steven Binder
Corporate headquarters
Westlake Village, California

Forecasts